- Filed
- Mar 19, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 17, 2026 | 89.97M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 13.6M sh |
| Shares Diluted restated | Q1 2026 · Dec 31, 2024 | 449.13K sh |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$8.53M |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | −$1.34M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $45.36K |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $137.29K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $55.71M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $45.74M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.9M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $27.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.9M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $27.65M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.41M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $17.13M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $67.42M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $74.18M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$1.43 |
| Eps Diluted restated | Q1 2026 · Dec 31, 2024 | −$3.42 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$1.43 |
| Eps Basic restated | Q1 2026 · Dec 31, 2024 | −$3.42 |
| Net Income | Q1 2026 · Dec 31, 2025 | −$19.44M |
| Net Income | Q1 2026 · Dec 31, 2024 | −$1.54M |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$1.99M |
| Operating Income | Q1 2026 · Dec 31, 2024 | −$1.5M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $87.42K |
| Gross Profit | Q1 2026 · Dec 31, 2024 | $15.48K |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $15.68M |
| Cost Of Revenue | Q1 2026 · Dec 31, 2024 | $7.37K |
| Revenue | Q1 2026 · Dec 31, 2025 | $15.77M |
| Revenue | Q1 2026 · Dec 31, 2024 | $22.85K |